Critical role of extracellular matrix on induction by phenobarbital of cytochrome P450 2B1/2 in primary cultures of adult rat hepatocytes. 1995

S E Brown, and C P Guzelian, and E Schuetz, and L C Quattrochi, and H K Kleinman, and P S Guzelian
University of Colorado Health Sciences Center, Hepatobiliary Research Center, Denver, USA.

BACKGROUND Although it has been known for more than three decades that administration of lipophilic chemicals, including phenobarbital, produces liver hypertrophy, proliferation of smooth endoplasmic reticulum, and induction of liver microsomal enzymes such as cytochromes P450 (CYP) 2B1 and 2B2, the mechanism of this adaptive response remains largely unknown. An important advance was the recognition that, unlike cultures of continuously proliferating liver cell lines or cultures of primary non-proliferating adult rat hepatocytes maintained on either plastic or collagen-coated dishes, hepatocytes cultured on a basement membrane gel, Matrigel, formed rounded clusters and permitted phenobarbital-mediated induction in vitro of CYP 2B1/2 mRNAs and immunoreactive proteins (1). RESULTS We cultured adult rat hepatocytes on Type 1 collagen (Vitrogen) and allowed the cells to spread, flatten, and firmly attach to the substratum. Subsequent incubation in medium containing Matrigel as a soluble component, fully restored, in a dose-dependent manner, the ability to respond to phenobarbital with induction of CYP 2B1/2 mRNAs. Repeating this experiment with medium containing equivalent amounts of purified laminin, a major component of Matrigel, or with YIGSR or SIKVAV, two peptides known to mimic various activities of laminin, similarly restored phenobarbital responsiveness to hepatocytes cultured on Vitrogen. In contrast, use of equal amounts of SHA-23, a scrambled peptide relevant to SIKVAV, produced no such effect. None of these treatments caused a rounding or any other observable change in the flattened, cellular morphology, making it unlikely that cell-spreading or alterations in cell shape account for loss of such differentiated liver functions as phenobarbital induction of CYP 2B1/2 mRNAs in cultured hepatocytes on Vitrogen. Hepatocytes cultured on Matrigel in the presence of either colchicine, cytochalasins B and D, nocodazole, or taxol did not show induction of 2B1/2 mRNAs by phenobarbital specifically, while the amounts of both albumin and glucose-6-phosphate dehydrogenase (G6PD) mRNAs were unaffected. CONCLUSIONS We conclude that the process by which phenobarbital induced 2B1/2 mRNAs in hepatocytes appears to require highly concerted effects of specific extracellular components prominently involving laminin. This likely occurs through a signal transduction process requiring probably both microfilament and microtubular integrity.

UI MeSH Term Description Entries
D007797 Laminin Large, noncollagenous glycoprotein with antigenic properties. It is localized in the basement membrane lamina lucida and functions to bind epithelial cells to the basement membrane. Evidence suggests that the protein plays a role in tumor invasion. Merosin,Glycoprotein GP-2,Laminin M,Laminin M Chain,Chain, Laminin M,Glycoprotein GP 2,M Chain, Laminin
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010634 Phenobarbital A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations. Phenemal,Phenobarbitone,Phenylbarbital,Gardenal,Hysteps,Luminal,Phenobarbital Sodium,Phenobarbital, Monosodium Salt,Phenylethylbarbituric Acid,Acid, Phenylethylbarbituric,Monosodium Salt Phenobarbital,Sodium, Phenobarbital
D011509 Proteoglycans Glycoproteins which have a very high polysaccharide content. Proteoglycan,Proteoglycan Type H
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D003577 Cytochrome P-450 Enzyme System A superfamily of hundreds of closely related HEMEPROTEINS found throughout the phylogenetic spectrum, from animals, plants, fungi, to bacteria. They include numerous complex monooxygenases (MIXED FUNCTION OXYGENASES). In animals, these P-450 enzymes serve two major functions: (1) biosynthesis of steroids, fatty acids, and bile acids; (2) metabolism of endogenous and a wide variety of exogenous substrates, such as toxins and drugs (BIOTRANSFORMATION). They are classified, according to their sequence similarities rather than functions, into CYP gene families (>40% homology) and subfamilies (>59% homology). For example, enzymes from the CYP1, CYP2, and CYP3 gene families are responsible for most drug metabolism. Cytochrome P-450,Cytochrome P-450 Enzyme,Cytochrome P-450-Dependent Monooxygenase,P-450 Enzyme,P450 Enzyme,CYP450 Family,CYP450 Superfamily,Cytochrome P-450 Enzymes,Cytochrome P-450 Families,Cytochrome P-450 Monooxygenase,Cytochrome P-450 Oxygenase,Cytochrome P-450 Superfamily,Cytochrome P450,Cytochrome P450 Superfamily,Cytochrome p450 Families,P-450 Enzymes,P450 Enzymes,Cytochrome P 450,Cytochrome P 450 Dependent Monooxygenase,Cytochrome P 450 Enzyme,Cytochrome P 450 Enzyme System,Cytochrome P 450 Enzymes,Cytochrome P 450 Families,Cytochrome P 450 Monooxygenase,Cytochrome P 450 Oxygenase,Cytochrome P 450 Superfamily,Enzyme, Cytochrome P-450,Enzyme, P-450,Enzyme, P450,Enzymes, Cytochrome P-450,Enzymes, P-450,Enzymes, P450,Monooxygenase, Cytochrome P-450,Monooxygenase, Cytochrome P-450-Dependent,P 450 Enzyme,P 450 Enzymes,P-450 Enzyme, Cytochrome,P-450 Enzymes, Cytochrome,Superfamily, CYP450,Superfamily, Cytochrome P-450,Superfamily, Cytochrome P450
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug

Related Publications

S E Brown, and C P Guzelian, and E Schuetz, and L C Quattrochi, and H K Kleinman, and P S Guzelian
June 1993, Toxicology and applied pharmacology,
S E Brown, and C P Guzelian, and E Schuetz, and L C Quattrochi, and H K Kleinman, and P S Guzelian
July 2001, Biochemical pharmacology,
S E Brown, and C P Guzelian, and E Schuetz, and L C Quattrochi, and H K Kleinman, and P S Guzelian
November 1994, Biochemical pharmacology,
S E Brown, and C P Guzelian, and E Schuetz, and L C Quattrochi, and H K Kleinman, and P S Guzelian
April 1994, Toxicology letters,
S E Brown, and C P Guzelian, and E Schuetz, and L C Quattrochi, and H K Kleinman, and P S Guzelian
October 2011, Toxicology letters,
S E Brown, and C P Guzelian, and E Schuetz, and L C Quattrochi, and H K Kleinman, and P S Guzelian
December 2007, Toxicology and applied pharmacology,
S E Brown, and C P Guzelian, and E Schuetz, and L C Quattrochi, and H K Kleinman, and P S Guzelian
June 1993, Biochemical pharmacology,
S E Brown, and C P Guzelian, and E Schuetz, and L C Quattrochi, and H K Kleinman, and P S Guzelian
January 1996, Journal of biochemical toxicology,
S E Brown, and C P Guzelian, and E Schuetz, and L C Quattrochi, and H K Kleinman, and P S Guzelian
January 1993, In vitro cellular & developmental biology : journal of the Tissue Culture Association,
S E Brown, and C P Guzelian, and E Schuetz, and L C Quattrochi, and H K Kleinman, and P S Guzelian
August 2006, Toxicology in vitro : an international journal published in association with BIBRA,
Copied contents to your clipboard!